2019-05-05 10:34:00 Sun ET
technology social safety nets education infrastructure health insurance health care medical care medication vaccine social security pension deposit insurance
Former Vice President Joe Biden enters the next U.S. presidential race with many moderate-to-progressive policy proposals. At the age of 76, Biden stands out the presidential race as the favorite among Democratic voters in the recent polls. Biden enters the fray with a half-century of government experience with senior roles as the former chairman of Senate Foreign Relations Committee and vice president under President Barack Obama. On public finance, Biden cites high health care and energy costs as the primary threats to the economic prosperity of U.S. firms. Addressing these economic issues helps U.S. firms better compete worldwide. In addition, Biden supports better balancing the fiscal budget with deficit reductions. This fiscal policy stance contrasts with big tax cuts under the Trump administration. Biden indicates the essential need for U.S. banks to operate under the 5 key pillars of financial regulation: capital rules, low-leverage limitations, liquidity requirements, macroprudential stress tests, and deposit insurance constraints.
On agriculture, Biden opposes importing non-native species, which inadvertently alter domestic vegetation, compete with native species, introduce new diseases, and interfere with maritime commerce. Biden also supports a $15 minimum wage proposal, higher taxation on capital investment income, no tuition for public college students, and broader infrastructure.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2018-01-10 08:40:00 Wednesday ET

President Trump considers imposing retaliatory economic sanctions on Chinese products and services in direct response to China's theft and infringement
2025-03-03 04:11:06 Monday ET

Is higher stock market concentration good or bad for Corporate America? In recent years, S&P 500 stock market returns exhibit spectacular concentrati
2019-02-06 10:36:49 Wednesday ET

President Trump delivers his second state-of-the-union address to U.S. Congress. Several key themes emerge from this presidential address. First, President
2018-03-29 14:28:00 Thursday ET

Share prices tumble for technology stocks due to Trump's criticism of Amazon's tax avoidance, Facebook user data breach of trust, and Tesla autopilo
2019-01-19 12:38:00 Saturday ET

U.S. government shuts down again because House Democrats refuse to spend $5 billion on the border wall that would give President Trump great victory on his